- CIIX recently became the first Chinese company to sell CBD products in the United States
- The company launched a pop-up kiosk in the Glendale Galleria Mall to sell industrial hemp/CBD products
- CIIX recorded an 80 percent YOY increase in Q3 fiscal 2019 sales numbers
ChineseInvestors.com Inc. (OTCQB: CIIX), having established itself as a leading financial information website for Chinese-speaking investors in the United States and China, recognized unprecedented opportunities in the U.S. cannabis industry. Seeing that opportunity, CIIX began laying the groundwork to capitalize on the growing demand for cannabidiol (CBD)-based nutrition and health products. In doing so, CIIX became the first Chinese company to sell CBD products in the United States.
The company’s wholly owned subsidiary, ChineseHempOil.com Inc., has been doing business as Chinese Wellness Center (“CWC”) in the United States since 2017. The company specializes in the promotion and sales of high-end nutritional supplements and CBD hemp oil.
In a recent press release (http://ibn.fm/EaSpz), CIIX announced the launch of a pop-up mall kiosk in Glendale, California, through CWC. The kiosk began selling industrial hemp/CBD products on May 1, 2019. Products being offered include CWC’s own OptHemp product line, as well as NuLeaf Naturals, Joy Organics, Medterra, Hemp Meds and Medix.
“We are excited to bring our brand directly to the shoppers in the Greater Los Angeles area,” CIIX CEO Warren Wang stated in a news release. “Building on the current success of CWC’s industrial hemp/CBD product offerings, this pop-up kiosk will allow us to further engage with our local consumers beyond our online presence.”
CIIX is dedicated to the education of its customers and offers only the best products and solutions as it continues to expand its reach and educational awareness to the Chinese-speaking community. The company’s vision for excellence, along with its ability to identify and act on value-enhancing opportunities while providing the highest quality service to accommodate consumers’ needs, is what drives CIIX’s success.
For the third quarter of fiscal 2019, the company reported record revenues. An 81 percent year-over-year gain, totaling $1,444,822 in revenues, was attributed to a large increase in industrial hemp and CBD product sales.
“Our financial performance and highlights for the quarter are a testament to the popularity and demand for our CBD and hemp products,” Wang stated in a news release (http://ibn.fm/uzsTb). “As a result, we continue to make significant progress in our business through our investments intended to grow the platform for our consumer product lines.”
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.